A Study to Evaluate AB308 in Combination With AB122 in Participants With Advanced Malignancies
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Advanced Solid Tumor
- Cervical Cancer
- DLBCL
- Esophageal Cancer
- Gastric Cancer
- Gastroesophageal Junction Adenocarcinoma
- Lymphoma Non-Hodgkin
- Melanoma
- Multiple Myeloma
- NSCLC
- Type
- Interventional
- Phase
- Phase 1
- Design
- Allocation: Non-RandomizedIntervention Model: Sequential AssignmentMasking: None (Open Label)Primary Purpose: Treatment
Participation Requirements
- Age
- Between 18 years and 125 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT04772989
- Collaborators
- Not Provided
- Investigators
- Study Director: Medical Director Arcus Biosciences
Get Well Soon